Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer Ruby Khatun Khatun3 Sept 2018 10:30 AM ISTMumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...